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Abstract
The positive charge of the Arg70 residue in the cytoplasmic loop of the Tn10-encoded metal-tetracyclinerHq antiporter
  .. Tet B of Escherichia coli is essential for the tetracycline transport function Y. Someya and A. Yamaguchi, Biochemistry
 ..35, 9385–9391 1996 . In this study, we found that the R70A mutation was suppressed by the second-site mutation of
Thr171 to Ser. The T171S mutation suppressed any mutations at position 70 regardless of the amino acid residue
introduced. The R70A and R70C mutations were also suppressed by the T171A or T171C mutations, but not by the T171Y
mutation, indicating that the decrease in the side chain volume at position 171 is essential for the suppression. Tetracycline
transport activity of the R70C mutant was stimulated by Hg2q because mercaptide formed between the SH group of Cys70
and Hg2q worked as a functional positively-charged side chain. The activity of the R70ArR71CrT171S mutant was also
stimulated by Hg2q, whereas those of the R70ArR71C, R71C, and R71CrT171S mutants were not, indicating that the
T171S mutation causes the switching of the functional positive charge at position 70 to 71. Since Thr171 is in the middle of
the transmembrane helix VI, the switching may be based on a remote conformational effect. q 1997 Elsevier Science B.V.
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1. Introduction
Tetracycline resistance of bacterial cells is mainly
mediated by the integral membrane protein desig-
w xnated as TetA 1 , which catalyzes the antiport of a
divalent cation-tetracycline complex and a proton
w x   ..2,3 . The class B TetA protein Tet B encoded by
transposon Tn10 is composed of 401 amino acids
w x4,5 , and the 12 membrane-spanning structure was
w xexperimentally established 6–8 .
The amino acid sequence motif, GXXXDRXGRR,
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is conserved throughout secondary transporters un-
q .iporters, and H -coupled symporters and antiporters ,
and is commonly found in their cytoplasmic hy-
drophilic loop2–3 connecting transmembrane seg-
. ments 2 and 3 and loop8–9 connecting transmem-
. w xbrane segments 8 and 9 9–12 . Characteristic of
antiporters, the second sequence motif in loop8–9 is
w xchanged to GXXXXRXGER 13 . We have already
introduced many mutations of residues within loop2–
w x w x  .3 14,15 and loop8–9 13 of the Tn10–Tet B , and
proposed the possible role of these motifs as a gate
w xfor substrate entry into a translocation channel 16,17 .
Mutagenesis studies on loop2–3 in other secondary
 . w xtransporters, i.e. a-ketoglutarate permease KgtP 18
0005-2728r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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 . w xand lactose permease LacY 19,20 of E. coli, gave
essentially similar results as ours, indicating the gen-
eral role of this motif.
 .Arg70 of the Tet B protein that occupies the ninth
position of the GXXXDRXGRR motif is the only
functionally essential positively-charged residue in
loop2–3, since only the R70K mutant retained the
w xtetracycline transport activity 15 . Although it has a
neutral side chain, the R70C mutant showed signifi-
cant activity in the presence of Co2q or Hg2q ions.
This was based on that the mercaptide formed be-
tween the SH group of Cys70 and Hg2q or Co2q
works as a functional positively-charged side chain
w x21 .
In this manuscript, we report on the second-site
suppressor mutation of the Arg70 mutation. It was
previously found that the loss of a functional nega-
tively-charged residue in the transmembrane region
was suppressed by a second-site mutation by which a
new negatively-charged residue was introduced in the
w xtransmembrane region 22,23 . The second-site sup-
pression for the Arg70 mutation was not based on the
introduction of a new positively-charged residue, but
that Arg71 originally present substitute as the func-
tional positive charge via a remote conformational
effect evoked by the decrease in the side chain
 .volume at the second-site Thr171 in the middle of
the transmembrane helix VI.
2. Materials and methods
2.1. Materials
w 3 x w 32 x7- H Tetracycline and a- P dCTP were pur-
chased from Du Pont-New England Nuclear and
Amersham, respectively. The Sequenase version 2.0
7-deaza-dGTP kit was obtained from U.S. Biochemi-
cals. Restriction and modifying enzymes were ob-
 .tained from Takara Kyoto, Japan and Toyobo
 .Osaka, Japan . All other chemicals were of reagent
grade and from commercial sources.
2.2. Bacterial strains and plasmids
w xE. coli W3104 24 was used for revertant isola-
tion, preparation of inverted membrane vesicles and
measurement of tetracycline resistance. CJ236 and
BMH71–18 mutS were used for site-directed muta-
w x w xgenesis by the method of Kunkel 25 . TG1 26 was
w xused for all other DNA manipulations. pCT1183 23 ,
which is a multicopy plasmid containing the entire
w xtetR and tetA genes, or pER 27 , which is a subclone
of the first half of the tetA gene, was used as a
template for site-directed mutagenesis. Low-copy
w xnumber plasmid pLGT2 27 was used for expression
of the tet gene.
2.3. Construction of mutant plasmids
Mutagenesis for Thr171“Ala, Cys and Tyr sub-
stitutions was performed by the method of Kunkel
w x X25 using the respective mutagenic primers, 5 -GGAA
AGCGACGATATTT-3X, 5X-AGGAAACAGACGA-
TATTT-3X, and 5XAGGAAATAGACGATATTT-3X
the complementary sequences of codons for Ala171,
.Cys171 and Tyr171 are underlined . Mutations were
detected as the disappearance of the original SspI
 .AATATT“GATATT and confirmed by DNA se-
quencing. The 485 bp EcoRV–EcoRI fragments con-
taining the Thr171 mutations were cut out from
pCTT171A, pCTT171C and pCTT171Y, and ex-
changed with the corresponding regions of pLGT2 to
construct low-copy-number plasmids pLGT171A,
pLGT171C and pLGT171Y, respectively. Single mu-
tant plasmids as to position 70 have been already
w xconstructed 15,21 . Arg70–Thr171 double mutant
plasmids were constructed by ligation of the
EcoRI–EcoRV vector fragment from pLGT2, the
266 bp EcoRV–MluI fragment containing an Arg70
mutation, and the 219 bp MluI–EcoRI fragment con-
taining a Thr171 mutation. The resultant plasmids
were designated as such as pLGR70ArT171A, for
example.
Mutagenesis for Arg67“CysrArg70“Ala and
Arg70“AlarArg71“Cys double mutations was
performed with the multi-copy pER plasmid by the
method of Kunkel using the respective mutagenic
primers, 5X-ATGTCTGACTGTTTTGGAGCTCGCC-
X CAGTG-3 the codons for Cys67 and
. XA la70 are underlined , and 5 -C G A TT -
X TGGTGCATGCCCAGTGC-3 the codons for Ala70
.and Cys71 are underlined . Mutations were detected
 .as the appearance of SacI GAGCTT and SphI
 .GCATGC sites, respectively, and confirmed by
DNA sequencing. Low-copy number plasmids
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 .pLGR67CrR70A and pLGR70ArR71C containing
the Cys67rAla71 and Ala71rCys71 double muta-
tions were constructed by exchange of the 485 bp
EcoRV–EcoRI fragments from the respective pER
plasmids with the corresponding regions of pLGT2.
Low-copy number plasmids containing the Ser171
mutation were constructed by ligation of the
EcoRI–EcoRV vector fragment from pLGT2, the
266 bp EcoRV–MluI fragment containing a
Arg67rArg70 or Arg70rArg71 mutation, and the
219 bp MluI–EcoRI fragment containing a Ser171
mutation.
2.4. Preparation of in˝erted membrane ˝esicles and
transport assays
Inverted membrane vesicles were prepared by
passing E. coli W3104 cells harboring pLG-plasmids
through a French pressure cell, suspended in 50 mM
 .MOPS–KOH buffer pH 7.0 containing 0.1 M KCl,
w x w3 xand stored at y808C 15 . H Tetracycline uptake by
inverted membrane vesicles were assayed as de-
w xscribed 21 . Inverted vesicles were energized with
NADH and then exposed to a solution comprising
w3 x10 mM H tetracycline and 50 mM CoCl for the2
indicated times. The effect of Hg2q ions on tetra-
cycline uptake was examined in the presence of
10 mM HgCl .2
2.5. Other methods
Measurement of the tetracycline resistance level
and Western blotting were performed as described
w xpreviously 21 .
3. Results
3.1. Isolation of the second-site suppressor mutant of
the R70A mutant
E. coli W3104 cells harboring pLGR70A express-
 . w xing the R70A mutant Tet B protein 15 were spread
 . w xFig. 1. Secondary structure of Tn10–Tet B determined by the site-directed chemical labeling of the Cys-scanning mutants 8 . The Arg70
 .and Thr171 residues are enclosed in ellipsoids. Several charged residues important for the Tet B function are also shown.
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on a YT agar plate containing 100 mg of tetra-
cyclinerml, and then incubated at 378C. After 3
days, several colonies that had appeared were re-
streaked onto a YT agar plate containing 100 mg of
tetracyclinerml. Plasmid DNAs were isolated from
tetracycline-resistant colonies and reintroduced into
E. coli W3104, and tetracycline resistance was
checked. The tetA gene segments of these plasmids
were sequenced, and the codon change of ACT“
TCT, corresponding to the amino acid change of
Thr171“Ser, was identified, without alteration of
the original Ala70 mutation. Therefore the revertant
plasmid was designated as pLGR70ArT171S. Thr171
is located in the middle of putative transmembrane
 .segment VI Fig. 1 , and not to be close to the Arg70
residue. The R70ArT171S double mutant exhibited
the wild-type high level of tetracycline resistance
 .Table 1 . This was not due to the increase in the
expression level of the R70ArT171S protein in the
membrane, as judged by Western blot analysis Fig.
.2 .
3.2. The effects of ˝arious Thr171 mutations on
˝arious Arg70 mutants
Thr171 was replaced with an Ala, Cys or Tyr
residue by site-directed mutagenesis. As shown in
Table 1, the T171S, T171A and T171C mutations
almost completely suppressed both the R70A and
R70C mutations, whereas the T171Y mutation did
not. The expression of these mutant proteins were
 . almost the same as that of the wild-type Tet B Fig.
.2 . These results indicate that the replacement of
Thr171 to a residue having smaller side chain is
essential for suppression. Single mutation at position
171 did not affect the tetracycline resistance level
 .Table 1 .
Next the Ser171 mutation was combined with
various Arg70 mutations. The expression level of
 .Fig. 2. Western blot analysis of mutant Tet B proteins. Inverted
membrane vesicles containing 5mg of proteins were separated by
SDS–polyacrylamide gel electrophoresis, and then electrically
transferred onto nitrocellulose membrane. Wild-type and mutant
 .Tet B proteins were detected using anti-C-terminal peptide anti-
serum and alkaline phosphatase-conjugated goat anti-rabbit IgG.
There was no significant difference in the amounts of the wild-
 .  .type Tet B protein and mutant proteins. A , Lane 1, wild-type
 .Tet B ; lane2, T171S; lane 3, T171A; lane 4, T171C; lane 5,
 .T171Y. B , Lane 1, R70A; lane 2, R70ArT171S; lane 3,
R70ArT171A; lane 4, R70ArT171C; lane 5, R70ArT171Y;
lane 6, R70C; lane 7, R70CrT171S; lane 8, R70CrT171A; lane
 .9, R70CrT171C; lane 10, R70CrT171Y. C , Lane 1, R70S;
lane 2, R70SrT171S; lane 3, R70K; lane 4, R70KrT171S; lane
5, R70D; lane 6 R70DrT171S; lane 7, R70L; lane 8,
 .R70LrT171S; lane 9, R70W; lane 10, R70WrT171S. D , Lane
1, R67C; lane 2, R67CrT171S; lane 3, R71C; lane 4,
R 7 1 C r T 1 7 1 S ; lan e 5 , R 6 7 C r R 7 0 A ; lan e 6 ,
R67CrR70ArT171S; lane 7, R70ArR71C; lane 8,
R70ArR71CrT171S.
 .these mutant proteins were not altered Fig. 2 . The
Ser171 mutation elevated about 16-fold the tetra-
cycline resistance levels of all the Arg70 mutants
 .Table 2 . The MIC values for double mutants de-
Table 1
 .The effects of substitutions at position 171 on the minimum inhibitory concentrations MIC of tetracycline for the R70A and R70C
mutants a
Thr171 mutations
 .Arg70 mutations None Thr171 Thr171“Ser Thr171“Ala Thr171“Cys Thr171“Tyr
 .None Arg70 200 200 200 200 200
Arg70“Ala 12.5 200 100 100 3.1
Arg70“Cys 12.5 200 100 100 3.1
a MIC expressed in mgrml. MIC for E. coli W3104 without a plasmid is 0.8 mgrml.
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Table 2
The effect of the T171S mutation on the minimum inhibitory
concentrations of tetracycline for various mutants at position 70 a
Thr171 mutations
 .Arg70 mutations None Thr171 Thr171“Ser
 .None Arg70 200 200
Arg70“Ala 12.5 200
Arg70“Cys 12.5 200
Arg70“Lys 12.5 200
Arg70“Ser 12.5 200
Arg70“Asp 0.8 12.5
Arg70“Leu 0.8 12.5
Arg70“Trp 0.8 12.5
a MIC expressed in mgrml. MIC for E. coli W3104 without a
plasmid is 0.8 mgrml.
pended on those for the corresponding Arg70 single
mutants. It appears that suppression by the Ser171
mutation was not dependent on the nature of the side
chain at position 70.
3.3. Effects of mercuric ions on the tetracycline
transport acti˝ities of ˝arious mutants as to positions
67, 70, 71 and 171
 .Loop2–3 of Tet B contains three Arg residues;
Arg67, Arg70 and Arg71. Among them, only Arg70
w xis essential for function 15 . We constructed the
R67C, R70C, and R71C mutants in combination with
the T171S mutation and investigated the effect of
mercuric ions on the transport activities of these
mutants. These mutant proteins were normally pro-
 .duced in the membrane Fig. 2 .
Table 3 shows the initial rates of tetracycline
uptake by inverted membrane vesicles in the absence
or presence of Hg2q ions. These data were the
averages of at least three independent assays. First of
all, neither the transport activities of the R67C nor
R71C single mutant were affected by Hg2q, consis-
tent with that these residues are not essential for
function. On the other hand, the activity of the R70C
2q w xsingle mutant was 3.2-fold stimulated by Hg 21 .
As for the double mutants containing the Arg-to-Cys
mutation and the T171S mutation, the activities of the
R67CrT171S and R71CrT171S mutants were rather
inhibited by Hg2q, whereas that of the R70CrT171S
mutant was 1.8-fold stimulated. It should be noted
that the R70C single mutant 1.2 nmolrmg
.proteinr15 s and the R70CrT171S double mutant
 .1.1 nmolrmg proteinr15 s have almost the same
transport activity in the presence of Hg2q. This find-
ing, in consideration with the results of the Thr171
 .single mutants Table 1 , indicates that the T171S
 .mutation did not affect the activity of Tet B proteins
having a positivly-charged side chain at position 70.
For the mutants containing the R70A mutation, the
T171S mutation caused some interesting results. The
activities of the R67CrR70A and R70ArR71C dou-
Table 3
The effect of HgCl on tetracycline uptake by inverted membrane vesicles a2
3 3 2q bw x w xTetA proteins H Tetracycline H Tetracycline uptake in the Hg -activation
uptake in the absence of presence of 10 mM HgCl2
 .  .of HgCl nmolrmg proteinr15 s nmolrmg proteinr15 s2
Wild-type 2.2"0.2 2.0"0.2 0.9
R67C 1.9"0.1 1.6"0.1 0.8
R70C 0.38"0.03 1.2"0.1 3.2
R71C 2.7"0.2 2.8"0.2 1.0
R67CrT171S 0.87"0.07 0.42"0.03 0.5
R70CrT171S 0.60"0.05 1.1"0.1 1.8
R71CrT171S 1.2"0.1 0.81"0.06 0.7
R67CrR70A 0.26"0.02 0.27"0.02 1.0
cR70ArR71C y y y
R67CrR70ArT171S 0.87"0.07 0.62"0.05 0.7
R70ArR71CrT171S 0.12"0.01 0.35"0.03 2.9
a w3 x w3 xNADH-dependent H tetracycline uptake was measured in the presence of 10 mM H tetracycline and 50 mM CoCl plus or minus2
10 mM HgCl . Experiments were performed at least three times. Data are presented as means"S.D.2
b Ratio of uptake in the presence of HgCl to uptake in its absence.2
c No activity.
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ble mutants were not affected by Hg2q. The
R67CrR70ArT171S triple mutant was also not af-
fected by Hg2q. In contrast, the activity of the
R70ArR71CrT171S triple mutant was 2.9-fold
stimulated by Hg2q, indicating that the mercaptide
formed between Cys71 and Hg2q works as a func-
tional positive charge. In other words, when Arg70
was neutralized, the functional positively-charged side
chain in loop2–3 was switched from position 70 to
position 71 by the T171S mutation.
4. Discussion
A pseudorevertant was isolated from the R70A
 .mutant of Tet B , which had the second-site mutation
of T171S. The suppression was independent of the
nature of a side chain at position 70, and the decrease
in the side chain volume of Thr171 was essential for
suppression.
Arg70 is located in the cytoplasmic loop2–3,
whereas Thr171 is in the middle of the transmem-
 .brane helix VI Fig. 1 . This topology is evidenced
by a lot of experimental results including the reactiv-
w xity of Cys-scanning mutants with SH reagents 28 .
We observed that the T171C mutant did not react
w14 xwith C N-ethylmaleimide while the R70C mutant
was highly reactive with N-ethylmaleimide data not
.shown , confirming that Thr171 is burried in the
membrane and Arg70 is exposed to the aqueous
phase. Thus it is not likely that Arg70 and Thr171 are
spatially close to each other. In addition, none of the
suppressor mutation at position 171 directly compen-
sated for the loss of a positive charge at position 70.
Therefore the second-site suppressor mutation should
be due to a remote conformational effect.
The observation that the R70ArR71CrT171S
triple mutant was activated by Hg2q but that the
R70ArR71C double mutant was not activated sug-
gests the switching of functional positively-charged
side chain from position 70 to 71 by the T171S
mutation. The activity of the R70CrT171S double
mutant in the presence of Hg2q was similar to that of
the R70C single mutant. In the absence of Hg2q, the
former had higher activity than the latter. As a result,
the degree of Hg2q-activation of the R70CrT171S
double mutant is lower than that of the R70C single
mutant. These observations can be interpretted in
 .terms of that 1 a positive charge at position 70 can
 .work regardless of the T171S mutation, or 2 the
Cys70 mercaptide is more effective as a functional
positive charge than Arg71 even in the T171S mu-
tant.
Most second-site mutations suppressing the loss of
a charged residue seem to be classifiable into two
 .types: 1 the loss of the charge is compensated for
by the additional loss of an opposite charge, the
charges being ion-paired with each other in the wild-
w x  .type protein 29–32 , and 2 the loss of the charge is
compensated for by introduction of the same charge
w xto another position 22,23,33–36 . Mechanism of
suppression described in this report may be a novel
one that the loss of a charge at the first mutation site
is compensated for by the neighboring charge origi-
nally present via the subtle structural change induced
by the second-site mutation.
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